What's new

Human medicines European public assessment report (EPAR): Alunbrig, brigatinib, Date of authorisation: 22/11/2018, Revision: 10, Status: Authorised

Human medicines European public assessment report (EPAR): Alunbrig, brigatinib, Date of authorisation: 22/11/2018, Revision: 10, Status: Authorised

Apr 25, 2025 - 16:32
 0
Human medicines European public assessment report (EPAR): Alunbrig, brigatinib, Date of authorisation: 22/11/2018, Revision: 10, Status: Authorised
Human medicines European public assessment report (EPAR): Alunbrig, brigatinib, Date of authorisation: 22/11/2018, Revision: 10, Status: Authorised
Read More

Tags:

Previous Article

STAT+: Vanderbilt medical center warns suppliers not to raise prices due to tari...

Next Article

The D Brief: India-Pakistan tensions rise; China’s ‘ChatGPT for robots’; Golden ...

Related Posts

Human medicines European public assessment report (EPAR): Erbitux, cetuximab, Date of authorisation: 29/06/2004, Revision: 33, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 19, 2025  0

EMEA-003438-PIP02-23

EMEA-003438-PIP02-23

Mar 18, 2025  0

Orphan designation: Autologous T lymphocyte-enriched population of cells transduced with a lentiviral vector encoding a chimeric antigen receptor targeting human B cell maturation antigen with 4-1BB and CD3-zeta intracellular signalling domains Treatment of multiple myeloma, 04/06/2020 Withdrawn

Orphan designation: Autologous T lymphocyte-enriched po...

Apr 4, 2025  0